UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 383

Sortiert nach

STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors

Molecular cancer therapeutics, 2022-02, Vol.21 (2), p.282-293

2022

Link zum Volltext

Verfügbarkeit prüfen

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.8037-8050

2003

Link zum Volltext

Verfügbarkeit prüfen

Ultra-performance hydrophilic interaction liquid chromatography/tandem mass spectrometry for the determination of everolimus in mouse plasma

Rapid communications in mass spectrometry, 2009-05, Vol.23 (10), p.1461-1466

2009

Link zum Volltext

Verfügbarkeit prüfen

The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity

The Journal of biological chemistry, 2005-09, Vol.280 (35), p.31101-31108

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of Exemestane and Tamoxifen in a Postmenopausal Breast Cancer Model

Clinical cancer research, 2004-11, Vol.10 (21), p.7375-7381

2004

Link zum Volltext

Verfügbarkeit prüfen

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (12), p.5380-5389

2005

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model

JNCI : Journal of the National Cancer Institute, 2004-03, Vol.96 (6), p.456-465

2004

Link zum Volltext

Verfügbarkeit prüfen

Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens

Clinical cancer research, 2003-01, Vol.9 (1 Pt 2), p.455S-9S

2003

Link zum Volltext

Verfügbarkeit prüfen

Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models

International journal of cancer, 2009-12, Vol.125 (11), p.2711-2720

2009

Link zum Volltext

Verfügbarkeit prüfen

Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo

Gynecologic oncology, 2008-04, Vol.109 (1), p.97-106

2008

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of the antitumor activity of tamoxifen and anastrozole by the farnesyltransferase inhibitor lonafarnib (SCH66336)

Anti-cancer drugs, 2007-09, Vol.18 (8), p.923-931

2007

Link zum Volltext

Verfügbarkeit prüfen

The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer

Breast cancer research and treatment, 1999-09, Vol.57 (2), p.183-192

1999

Link zum Volltext

Verfügbarkeit prüfen

Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor

The Journal of steroid biochemistry and molecular biology, 2000-12, Vol.75 (1), p.1-10

2000

Link zum Volltext

Verfügbarkeit prüfen

Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model

The Journal of steroid biochemistry and molecular biology, 2004-10, Vol.92 (3), p.155-165

2004

Link zum Volltext

Verfügbarkeit prüfen

A unique form of proliferating cell nuclear antigen is present in malignant breast cells

Cancer research (Chicago, Ill.), 1998-08, Vol.58 (15), p.3264-3269

1998

Link zum Volltext

Verfügbarkeit prüfen

Human breast cancer cells contain an error-prone DNA replication apparatus

Cancer research (Chicago, Ill.), 1998-08, Vol.58 (15), p.3259-3263

1998

Link zum Volltext

Verfügbarkeit prüfen

Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression

Advanced therapeutics, 2021-10, Vol.4 (10), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer

Cancer research (Chicago, Ill.), 2000-12, Vol.60 (23), p.6630-6640

2000

Link zum Volltext

Verfügbarkeit prüfen

The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity

The Journal of steroid biochemistry and molecular biology, 1998-11, Vol.67 (4), p.293-304

1998

Link zum Volltext

Verfügbarkeit prüfen

Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER

Cancer letters, 1996-02, Vol.99 (2), p.209-215

1996

Link zum Volltext

Verfügbarkeit prüfen

Reduced levels of cathepsin D associated with tamoxifen resistance and estrogen independence in the ZR-75-1 human breast cancer cell line

Cancer letters, 1996-02, Vol.99 (2), p.233-238

1996

Link zum Volltext

Verfügbarkeit prüfen

Identification of human plasma proteins using the Laemmli method of gel electrophoresis

Biochemical Society transactions, 1994-02, Vol.22 (1), p.26S

1994

Link zum Volltext

Verfügbarkeit prüfen

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

The New England journal of medicine, 2012-10, Vol.367 (16), p.1519-1528

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 383

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(324)

Publikationsform

Sprache

Englisch
(383)
Japanisch
(53)

Erscheinungsjahr

n.n

Thema

Science & Technology
(383)
Humans
(232)
Female
(126)
Male
(113)
Animals
(96)
Biological And Medical Sciences
(88)
Adult
(82)
Middle Aged
(80)
Medical Sciences
(57)
Aged
(54)
Mice
(54)
Oncology
(53)
Fundamental And Applied Biological Sciences. Psychology
(36)
Biochemistry & Molecular Biology
(35)
Adolescent
(29)
General & Internal Medicine
(29)
Treatment Outcome
(29)
Neurosciences & Neurology
(27)
Young Adult
(27)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models

STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens

Ultra-performance hydrophilic interaction liquid chromatography/tandem mass spectrometry for the determination of everolimus in mouse plasma

The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity

Effects of Exemestane and Tamoxifen in a Postmenopausal Breast Cancer Model

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model

Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens

Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models

Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo

Enhancement of the antitumor activity of tamoxifen and anastrozole by the farnesyltransferase inhibitor lonafarnib (SCH66336)

The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer

Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor

Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model

A unique form of proliferating cell nuclear antigen is present in malignant breast cells

Human breast cancer cells contain an error-prone DNA replication apparatus

Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression

Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer

The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity

Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER

Reduced levels of cathepsin D associated with tamoxifen resistance and estrogen independence in the ZR-75-1 human breast cancer cell line

Identification of human plasma proteins using the Laemmli method of gel electrophoresis

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

Aktive Filter

Suchergebnisse filtern